Enovis Corp (US.ENOV)
Capital Allocation Audit · Period: 2010 – 2026
Key Metrics
US.ENOV · YoY: 2026 Q1 vs 2025 Q1
| Metric | Value | YoY |
|---|---|---|
| FCF Conversion | -120.5% | ↓ |
| ROE | -0.6% | ↑ |
| Cash Conversion | - | → |
| D/E Ratio | 0.96 | ↓ |
| Gross Margin | 62.0% | → |
US.ENOV (Enovis Corp) | YoY: 2026 Q1 vs 2025 Q1 Metric Value YoY ----------------------------- FCF Conversion -120.5% ↓ ROE -0.6% ↑ Cash Conversion - → D/E Ratio 0.96 ↓ Gross Margin 62.0% →
Key Metrics
US.ENOV (Enovis Corp) | YoY: 2026 Q1 vs 2025 Q1
Metric Value YoY-----------------------------FCF Conversion -120.5% ↓ROE -0.6% ↑Cash Conversion - →D/E Ratio 0.96 ↓Gross Margin 62.0% →Audit Dimensions
Unlimited Companies
AppleMicrosoftAlphabet-AAmazonNVIDIAMeta PlatformsTeslaBerkshire Hathaway-BJPMorganVisaJohnson & JohnsonWalmartProcter & GambleExxon MobilUnitedHealthHome DepotMasterCardPfizerAbbVieCoca-ColaPepsiCoCostcoNetflixAdvanced Micro DevicesSalesforceDisneyNikeBoeingCaterpillarGoldman SachsAlibabaPDD HoldingsJD.comNIO IncLi AutoBaiduTaiwan SemiconductorASML HoldingEli Lilly and CoBroadcomCiscoOracleIntelAT&TVerizonMerck & CoTexas InstrumentsUnited Parcel ServiceRTX CorpLowe's Companies